Announced Mon, 20 Jul · 20:50 IST
Bajaj Healthcare Q1 FY27: revenue up 11.3%, PAT up 15.8%
Compliance View source PDF
BAJAJHCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-16.9%1-day move
₹391.00
prior close
₹390.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.7-5.1-4.7-4.9-16.9-18.7-17.1-18.2——————
Up moveDown movePending
AI summary
Bajaj Healthcare Q1 FY27: revenue at Rs 165.6 Cr, up 11.3% YoY and 8.2% sequentially. EBITDA rose 16.4% YoY to Rs 29.6 Cr, margin improved to 17.8% from 17%. PAT grew 15.8% YoY to Rs 13.7 Cr, margin at 8.3%. Gross margin expanded to 48.3% from 46.2%. Domestic API sales surged 27% YoY to Rs 92.3 Cr. API exports dipped 4.1% due to West Asia issues. The company became India's first to secure SEC recommendation for Cenobamate Tablets.
Likely market impact
Strong Q1 with double-digit profit growth, margin expansion, and a regulatory milestone in specialty formulations. Exports a near-term watch point.